India Clarifies Intent To Continue With Compulsory Licenses
This article was originally published in PharmAsia News
Executive Summary
India’s government has denied accounts it “privately reassured” the US pharmaceutical industry it would not issue compulsory licenses to override patents in order to let domestic players make less expensive, generic versions of branded drugs.